Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial

Kyoto University Substance (KUS) 121, an ATPase inhibitor of valosin-containing protein, is a novel neuroprotectant. We tested the safety and effectiveness of KUS121 in patients with acute central retinal artery occlusion (CRAO). We conducted an investigator-initiated, first-in-humans, phase 1/2 cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Hanako Ohashi, Muraoka, Yuki, Hata, Masayuki, Sumi, Eriko, Ikeda, Takafumi, Nakagawa, Takayuki, Abe, Hiroyasu, Tada, Harue, Morita, Satoshi, Kakizuka, Akira, Yoshimura, Nagahisa, Tsujikawa, Akitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018138/
https://www.ncbi.nlm.nih.gov/pubmed/32053676
http://dx.doi.org/10.1371/journal.pone.0229068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018138/
https://www.ncbi.nlm.nih.gov/pubmed/32053676
http://dx.doi.org/10.1371/journal.pone.0229068

Ejemplares similares